Pre-blended in a single lyophilized vial — one reconstitution, one draw, one injection. GLOW combines three of the most researched repair peptides into the most comprehensive tissue regeneration protocol available.
GLOW is not a convenience product — it's a mechanistic decision. Each of the three components targets a distinct healing pathway. Together, they cover collagen and extracellular matrix rebuilding, receptor-mediated tissue signaling, and cell migration with angiogenesis — the full spectrum of tissue repair biology.
GHK-Cu drives fibroblast activation and collagen synthesis. BPC-157 stimulates tendon fibroblast proliferation. TB-500 promotes the formation of new connective tissue. All three work on the extracellular matrix through complementary mechanisms.
The most complete research-backed tendon healing protocol available. BPC-157 + TB-500 is the established recovery stack; GHK-Cu adds the collagen synthesis and gene expression reset that makes repairs more structurally complete.
BPC-157 activates VEGFR2 to recruit blood vessel growth at injury sites; TB-500 drives systemic angiogenesis through actin/cell migration pathways. Combined, they create a richer vascular environment for healing tissue.
GHK-Cu's documented effects on collagen, elastin, and gene expression reset make GLOW effective for skin quality alongside musculoskeletal repair — a dual benefit not available in peptides focused solely on injury.
GHK-Cu influences ~31% of human genes. In the context of GLOW, this means the healing environment at injury and skin sites is actively reprogrammed toward a more youthful, regenerative state.
No three separate reconstitutions. No calculating three separate doses. One vial, one draw, one injection — pre-blended at the ratios most commonly used in research community protocols.
Reconstitute with bacteriostatic water. The GHK-Cu is dosed at 50mg per vial, so dosing is based on fraction of the vial content.
| Parameter | Detail |
|---|---|
| Reconstitution | Add 2–5 mL bacteriostatic water gently to lyophilized powder |
| Frequency | Once daily or every other day |
| Route | Subcutaneous — abdomen, upper thigh |
| Cycle Length | 4 – 12 weeks depending on protocol goals |
| Storage (reconstituted) | Refrigerate; use within 30 days |
The value of GLOW is not just convenience — it's precision. The 5:1 ratio of GHK-Cu to BPC-157/TB-500 reflects the typical research community practice of using more GHK-Cu per cycle (larger molecules, higher dose needed for collagen effects) alongside the smaller BPC-157 and TB-500 doses that produce tissue signaling effects. A pre-blended vial ensures consistent ratios in every injection without manual mixing.
KLOW adds KPV (a tripeptide with potent anti-inflammatory and gut-healing properties) to the GLOW formula. If your primary research focus is gut inflammation, IBD models, or combined gut+tissue healing, KLOW is the more targeted choice. GLOW is the core recovery and regeneration stack.
GLOW is a pre-blended peptide combination sold for research purposes only. None of the components (GHK-Cu, BPC-157, TB-500) are FDA-approved drugs. The information on this page is educational and does not constitute medical advice. Consult a qualified healthcare professional before any peptide protocol.
Pre-blended. Triple-analyte COA. Finnrick Analytics verified. Ships within 24 hours.
Get Started Today